|Articles|November 21, 2022
Quality Control Analysis of Oligonucleotide Therapeutics: One Platform Method for Determining Identity, Purity, and Quantity
Author(s)Waters
Related Content
Sponsored Content
Trending on Pharmaceutical Technology
1
The Implications of Isatuximab-irfc’s FDA Approval for Multiple Myeloma
2
The FDA Moves to Modernize Drug Manufacturing Registration
3
PharmTech Weekly Roundup–July 10, 2026
4
What the Ocrelizumab Deal Does for the Multiple Sclerosis Biosimilar Pipeline
5